Medicare, Massachusetts Medicaid (MassHealth), most commercial plans
What kind of place is this?
AI summary of this centre's website
Research FocusedInfusion On-SiteOne Doctor Relationship
You are in a dedicated MS center built around ongoing specialty care, infusion treatment, and research involvement. You can expect a large team, coordinated support, and access to both treatment and study options. This isn't a virtual-first practice, so most care is centered on in-person visits.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access5/5
Support Services4/5
Clinical Trials & Research4/5
Insurance & Navigation Help5/5
Scheduling & Virtual Care3/5
About The Elliot Lewis Center for Multiple Sclerosis Care
AI summary of this centre's website
This center combines on-site infusion therapy with a clinical research program, giving you access to treatment and study opportunities in one place. It is also a large, dedicated MS practice with a multidisciplinary team.
The Elliot Lewis Center for Multiple Sclerosis Care treats multiple sclerosis, relapsing MS, progressive MS, neuromyelitis optica, MOG associated disease, and transverse myelitis. You can receive neurology consultations, infusion therapies, lab testing at the time of infusion, and support with insurance and financial assistance. The center has a clinical research program and offers a team-based model with physicians, nurses, research staff, and social work support.
Good to know
On-site infusion therapy available by appointment Monday through Friday
Free on-site parking is available
Urgent appointments are scheduled within 24 hours when possible
Doctors are reachable during business hours and after hours by email and phone
Uninsured patients may be eligible for a sliding-scale self-pay rate
The Elliot Lewis Center for Multiple Sclerosis Care is a dedicated MS practice in Wellesley, MA. You can receive care from a multidisciplinary team that includes physicians, nurses, research coordinators, a social worker, and support staff. The center offers both on-site infusion therapy and clinical research. Patients also benefit from insurance and benefits coordination and help with financial assistance program enrollment.
multiple sclerosis careneurology consultationson-site infusion therapyclinical researchinsurance and benefits coordinationfinancial assistance program enrollmentlab testing at time of infusioninfusion therapiesdisease-modifying therapies
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
FAQs from The Elliot Lewis Center for Multiple Sclerosis Care
The center treats multiple sclerosis, relapsing MS, progressive MS, neuromyelitis optica, MOG associated disease, and transverse myelitis. Care is led by specialists who focus on these conditions.
Yes. The Elliot Lewis Center has an on-site infusion center, and infusion treatments are available by appointment Monday through Friday.
Joshua Katz, MD, is the Director, and Andrew Bouley, MD, is the Co-Director. You are also supported by a multidisciplinary team that includes physicians, nurses, research staff, a social worker, and support staff.
Yes. The Elliot Lewis Center has a clinical research program, and it is also listed as having active clinical trials. If you are interested in research participation, the team can help guide you.
The center accepts Medicare, Massachusetts Medicaid (MassHealth), and most commercial plans. It also provides insurance and benefits coordination, financial assistance program enrollment, and a full insurance support process.
Compare Massachusetts MS Centers
Center
Type
Infusion
Virtual
Experience
T
The Elliot Lewis Center for Multiple Sclerosis Care
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.